Screening for Infectious Mononucleosis
Screen for infectious mononucleosis when patients present with the classic triad of fever, pharyngitis, and posterior cervical lymphadenopathy, particularly in adolescents and young adults aged 15-24 years; use a rapid heterophile antibody test (monospot) as the initial screening test, but confirm positive results with EBV-specific antibody testing (viral capsid antigen IgM/IgG) due to the test's low positive predictive value. 1, 2
When to Screen
Screen for infectious mononucleosis when patients present with:
- Classic triad: Fever, tonsillar pharyngitis, and lymphadenopathy (especially posterior cervical) 1, 3
- Additional supportive features:
The highest clinical suspicion should be in adolescents and young adults 15-24 years old, as this is the peak age group 1, 3.
Preferred Testing Algorithm
Initial Testing (Cost-Effective Approach)
Complete blood count with differential 1:
Rapid heterophile antibody test (monospot) 1:
Confirmatory Testing
All positive monospot results should be confirmed with EBV-specific antibody testing 2. This is particularly important given the low positive predictive value and implications for activity restriction.
EBV viral capsid antigen (VCA) antibody testing 1, 4:
- Most sensitive and specific test available 4
- More expensive and takes longer to process than monospot 1
- Order when:
Supporting Laboratory Tests
Liver function tests (transaminases) 2, 6:
- Elevated liver enzymes increase clinical suspicion for IM when monospot is negative 1
- All patients with acute IM have elevated transaminases 2
- Important caveat: Serial monitoring of liver function tests is NOT required in immunocompetent adults with subclinical derangement, as resolution occurs spontaneously (median 32 days, maximum 10 months) without liver disease sequelae 6
Common Pitfalls to Avoid
Do not rely solely on a positive monospot test - the specificity is lower than historically reported (90.6% vs. previously thought higher), and positive predictive value is poor at 36.4% 2. Always confirm with EBV serology.
Do not rule out IM based on a negative monospot alone - the negative predictive value is excellent at 98.5%, but false negatives occur early in illness and in young children 1, 2. If clinical suspicion is high with atypical lymphocytes present, proceed directly to EBV-specific antibody testing 5.
Beware of the diagnostic dilemma - patients can be both heterophile negative AND initially seronegative for EBV antibodies due to the evolving course of antibody development 5. In such cases, repeat EBV serology after 1-2 weeks if clinical suspicion remains high.
Do not order abdominal ultrasound routinely - it does not add diagnostic value in uncomplicated cases 6.